Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Search Results - Company

your search of 'Company' has 59 results.

sort by  Recent ▼
showing 1 - 12 of 59 results   

Gene therapy fail sees company stock price tumble

The share price of French-based biotech GenSight Biologics crashed recently, after results from its Phase III clinical trial of a gene therapy treatment for a rare blinding disease achieved the same results as the placebo control injection. Read more »

Spark share value increases following historic treatment

Spark Therapeutics has celebrated the first FDA-approved application of its US$425,000 (AU$547,550) Luxturna gene therapy treatment. Read more »

Opternative launches new software for optometry clinics

Healthcare technology company Opternative has released software that allows eyecare practices to include digital refractions and visual acuity tests on their websites. Read more »

Warby Parker receives $95 million in funding, analysts predict future IPO for the company

Warby Parker has raised US$75 million (AU$95.4 m) in series E funding, leading multiple analysts to predict the company is headed toward an initial public offering in the near future. Read more »

Former Unilever chief new CEO of Safilo

Former Unilever Italia boss Mr Angelo Trocchia will take over as the CEO of Italian multinational eyewear company Safilo, after Ms Luisa Delgado resigned from the position at the end of February citing personal reasons. Read more »

Eylea syringes linked to adverse patient reactions in the U.S

Regeneron has blamed syringes for adverse reactions experienced by some users of its best-selling anti-VEGF drug Eylea. Read more »

Court rejects Restasis patent strategy

The US Patent Trial and Appeal Board (PTAB) has ruled it has the authority to decide on the validity of patents covering Allergan’s dry eye drug Restasis, despite the multinational transferring ownership of them to a Native American tribe in an attempt to protect them from challenge. Read more »

Cooper companies set for leadership change next month

The Cooper Companies will have a new CEO next month, with long-time incumbent Mr Robert Weiss set to retire. Read more »

Allergan reports Q4 sales increase

Allergan has weathered revenue hits from products losing patent exclusivity to post a fourth quarter increase of 12% compared with the same time last year. Read more »

Johnson & Johnson use studies to promote dry eye treatment

Johnson & Johnson Vision has hailed the publication of two studies it says demonstrates the clinical benefits of its LipiFlow treatment for meibomian gland dysfunction (MGD). Read more »

HOYA continues record-breaking run

Tokyo-based optical company Hoya posted record high revenues during the third quarter last year and expects to see more profit growth for the first quarter in 2018. Read more »

Hubble begins European expansion in the UK

The US’ first direct-to-consumer subscription contact lens brand, Hubble, has been launched in the UK as part of the company’s second wave of global expansion. Read more »


Archives - Company

2018 Issues
2017 Issues
2016 Issues
Hot Stories


Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!